Ho Chi Minh City will struggle to attract private investors if it continues with stringent …
Read More »BioNTech’s Q1 vaccine sales triple but it still flags full-year decline
BioNTech’s 22UAy.DE first-quarter sales and earnings more than tripled thanks to demand for the Covid-19 vaccine it developed with Pfizer PFE.N, but the German biotech firm is still forecasting a full-year decline in vaccine sales. Quarterly revenues more than tripled from a year earlier to 6.37 billion euros ($6.73 billion), …
Read More »